QuidelOrtho is a pure-play diagnostics company that develops and manufactures technologies for detecting diseases and health conditions. Its portfolio includes tests for HIV, hepatitis C, influenza, strep, and COVID-19, built on technical domains such as immunoassay testing, molecular testing, lateral-flow and rapid antigen diagnostics, and PCR assays.
The company's products span the entire healthcare continuum, from home settings to hospitals, and from clinical laboratories to clinics. Its global footprint extends across point-of-care settings, clinical labs, and transfusion medicine, backed by a collective industry experience of more than 120 years.
Operating within the healthcare, diagnostics, and transfusion medicine sectors, QuidelOrtho maintains a presence in multiple geographic markets worldwide.
